DISEASE INDICATIONS: Risk of cardiovascular events

MANUFACTURER: Merck

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Verquvo is a prescription medication used in combination with other medications to treat heart failure with reduced ejection fraction in adults. Verquvo works by stimulating the production of cyclic guanosine monophosphate (cGMP) to relax blood vessels and reduce inflammation, allowing the heart to pump blood more efficiently.